The Application of Nanomaterials in Combating Antibiotic-Resistant Bacteria
A special issue of Antibiotics (ISSN 2079-6382).
Deadline for manuscript submissions: closed (1 April 2024) | Viewed by 426
Special Issue Editor
Special Issue Information
Dear Colleagues,
Antibiotic resistance is becoming increasingly prevalent among microbes today. It is one of the most serious major public health issue confronting the world's population. Due to the widespread use of antibiotics, a lack of prescriptions for patients, and the frequent dissemination of bacteria around the world among human beings, drug resistance has developed. According to the Centers for Disease Control and Prevention (CDC), approximately 10% of patients admitted to hospitals in the United States have multidrug-resistant illnesses. It is estimated that many patients die as a result of their illnesses. As a result, the situation is considerably worse in developing countries, where approximately 75% of all infections occur. Statistically, South Africa's results are likely to fall within the respective ranges. Although new antibiotics have been developed during the last century, they are inadequate to treat a variety of antibiotic-resistant bacteria. Consequently, a novel antimicrobial medication that is noncorrosive and nontoxic, and that operates more effectively and rapidly than current antibiotics, is necessary to address this growing public health risk. The use of photodynamic therapy (PDT) and the development of nanoformulations to reduce multidrug-resistant pathogen infections can involve in vitro, animal study, and clinical trial approaches.
This Special Issue aims to discover a therapeutic molecule and agent that will aid in the treatment of disease and illness in human beings and animals.
Dr. Mohd Ahmar Rauf
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Antibiotics is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- nanofabrication
- nanomaterials
- drug resistance
- infection
- nano formulations
- antimicrobials
- photodynamic therapy
- reactive oxygen species
- drug delivery
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue polices can be found here.
